Neurologic morbidities, psychological distress, and functional independence in adult survivors of childhood cancer treated with CNS-directed therapies: A report from the Childhood Cancer Survivor Study.

Authors

null

Stefanie C. Vuotto

St. Jude Children's Research Hospital, Memphis, TN

Stefanie C. Vuotto , Kevin R. Krull , Chenghong Li , Mehmet Fatih Okcu , Daniel C. Bowers , Nicole J. Ullrich , Deokumar Srivastava , Rebecca M. Howell , Todd M. Gibson , Wendy M. Leisenring , Kevin C. Oeffinger , Leslie L. Robison , Gregory T. Armstrong , Tara M. Brinkman

Organizations

St. Jude Children's Research Hospital, Memphis, TN, Baylor College of Medicine - Texas Children's Cancer and Hematology Centers, Houston, TX, The University of Texas Southwestern Medical Center, Dallas, TX, Boston Children's Hospital, Boston, MA, The University of Texas MD Anderson Cancer Center, Houston, TX, Fred Hutchinson Cancer Research Center, Seattle, WA, Memorial Sloan Kettering Cancer Center, New York, NY

Research Funding

NIH

Background: Survivors of childhood cancer who received CNS-directed therapies are at risk for neurologic sequelae, which may adversely impact psychological functioning and independence in adulthood. Methods: Participants included 7,942 survivors of childhood cancer treated from 1970-99 with cranial radiation, intrathecal methotrexate or cytarabine (59% leukemia; 27% CNS tumor; 11% non-Hodgkin; 3% other; mean[SD] age = 25.5[5.8] yrs, time since diagnosis = 17.7[4.6] yrs). Self-reported neurologic conditions included stroke, seizure, sensory deficits, focal neurologic dysfunction, and severe headaches. Emotional distress symptoms (BSI-18) included anxiety, depression, and suicide ideation (SI). Functional independence was assessed using latent class analysis with six indicators (independent living, assistance with routine needs, assistance with personal care needs, ability to attend work/school, driver’s license, marital status). Multivariable regression models, adjusted for age, sex, race, pain, and health status, estimated relative risks (RR) and odds ratios (OR) for associations of neurologic morbidity with emotional distress and functional independence. Results: Prevalence of neurologic conditions was: 3% stroke; 11% seizure; 25% sensory deficits; 29% focal neurologic dysfunction; 31% severe headaches. In multivariable models, risk of emotional distress was associated with focal neurologic dysfunction (anxiety: RR 1.6; 95% CI 1.3-2.1; depression: RR 1.4; CI 1.2-1.7), sensory deficits (anxiety: RR 1.3; CI 1.0-1.6; depression: RR 1.3; CI 1.1-1.5; SI: RR 1.3; CI 1.0-1.6), and severe headaches (anxiety: RR 1.5; CI 1.2-1.9; depression: RR 1.6; CI 1.4-2.0; SI: RR 1.5; CI 1.2-1.8). Stroke (OR 0.3, CI 0.2-0.5), seizure (OR 0.2, CI 0.2-0.3), and focal neurologic deficits (OR 0.26, CI 0.2-0.3) were associated with decreased likelihood of functional independence. Conclusions: Childhood cancer survivors who develop neurologic morbidities are at-risk of emotional distress symptoms, including suicide ideation, and failure to attain independence in adulthood.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Pediatric Oncology

Track

Pediatric Oncology

Sub Track

Survivorship

Citation

J Clin Oncol 36, 2018 (suppl; abstr 10570)

DOI

10.1200/JCO.2018.36.15_suppl.10570

Abstract #

10570

Poster Bd #

243

Abstract Disclosures